PPARdelta agonists (Kalypsys)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePPARdelta agonists (Kalypsys)
Drug Alias NameKD-3020
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor delta agonists
TargetsPeroxisome proliferator-activated receptor delta
Therapy Area/IndicationsWounds and InjuriesMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKalypsys Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKalypsys Inc
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A